Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP

Watchlist Manager
Corbus Pharmaceuticals Holdings Inc Logo
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Watchlist
Price: 8.19 USD -1.8% Market Closed
Market Cap: 143.7m USD

Intrinsic Value

CRBP doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of CRBP.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CRBP Intrinsic Value
Not Available
Base Case Scenario
Compare CRBP to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CRBP?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Corbus Pharmaceuticals Holdings Inc

Current Assets 107.6m
Cash & Short-Term Investments 104m
Other Current Assets 3.6m
Non-Current Assets 1.9m
PP&E 1.6m
Other Non-Current Assets 385k
Current Liabilities 17.1m
Accounts Payable 2.7m
Accrued Liabilities 14.3m
Non-Current Liabilities 307k
Other Non-Current Liabilities 307k
Efficiency

Free Cash Flow Analysis
Corbus Pharmaceuticals Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Corbus Pharmaceuticals Holdings Inc

Revenue
0 USD
Operating Expenses
-75.9m USD
Operating Income
-75.9m USD
Other Expenses
8.4m USD
Net Income
-67.5m USD
Fundamental Scores

CRBP Profitability Score
Profitability Due Diligence

Corbus Pharmaceuticals Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

Corbus Pharmaceuticals Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CRBP Solvency Score
Solvency Due Diligence

Corbus Pharmaceuticals Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Corbus Pharmaceuticals Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CRBP Price Targets Summary
Corbus Pharmaceuticals Holdings Inc

Wall Street analysts forecast CRBP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRBP is 43.18 USD with a low forecast of 28.28 USD and a high forecast of 55.65 USD.

Lowest
Price Target
28.28 USD
245% Upside
Average
Price Target
43.18 USD
427% Upside
Highest
Price Target
55.65 USD
579% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Corbus Pharmaceuticals Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CRBP is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CRBP Insider Trading
Buy and sell transactions by insiders

CRBP News

Other Videos